STAT3 and head and neck squamous cell carcinoma: Inhibition of STAT3 signaling by STAT3-targeted siRNA or treatment with Stattic, a STAT3-specific inhibitor, abrogated the arginase dependent suppressive function of M-MDSCs in head and neck squamous cell carcinoma patients [28].